L-β-Homoalanini Hydrochloridis H-β-HoAla-OH.HCl CAS 58610-41-6 Puritas >98.0% (TLC) Factory Featured Image

L-β-Homoalanine Hydrochloridum H-β-HoAla-OH.HCl CAS 58610-41-6 Puritas >98.0% (TLC) Factory

Description:

Nomen chemicum: L-β-Homoalanini hydrochloridum

Synonyma: H-β-HoAla-OH

CAS: 58610-41-6

Puritas: >98.0% (TLC)

Aspectus: Alba vel Off-White Crystalline pulveris

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of L-β-Homoalanine Hydrochloride (CAS: 58610-41-6) with high quality, commercial production. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	L-β-Homoalanine Hydrochloridum
Synonyma	L-Beta-Homoalanine Hydrochloride;L-Beta-Homoalanine HCl;(S) -3-Aminobutanoicum acidum hydrochloridum;(S) -3-Aminobutric Acidum HCl;H-β-HoAla-OH.HCl;H-β-HoGlu-OH.HCl
CAS Number	58610-41-6
CATTUS Number	RF-CC342
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C4H9NO2·HCl
M. Pondus	139.58
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba vel Off-White Crystalline pulveris
Puritas / Analysis Methodus	>98.0% (TLC)
Imprimis Rotationes [α]D25	+22.0± 2.0º (C=1 in H2O)
Liquescens punctum	114.0~119.0℃
Damnum in Siccatio	<1.00%
NMR Imaginum	Congruunt cum Structure
Test Standard	Enterprise Standard
Consuetudinem	Amino acida;Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

L-β-Homoalanine hydrochloridum (CAS: 58610-41-6) uti potest ut medium in synthesi organica, sicut intermedium pharmaceuticum.Hydrochloridum hydrochloridum amino acidum derivativum L-β-Homoalanini est.Renuntiatum est adhiberi posse ad compositiones praeparandas ad infectionem HBV tractandam.